BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Durán-Lobato M, López-Estévez AM, Cordeiro AS, Dacoba TG, Crecente-Campo J, Torres D, Alonso MJ. Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape. Adv Drug Deliv Rev 2021;176:113899. [PMID: 34314784 DOI: 10.1016/j.addr.2021.113899] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Marqués M, Sorolla MA, Urdanibia I, Parisi E, Hidalgo I, Morales S, Salud A, Sorolla A. Are Transcription Factors Plausible Oncotargets for Triple Negative Breast Cancers? Cancers (Basel) 2022;14:1101. [PMID: 35267409 DOI: 10.3390/cancers14051101] [Reference Citation Analysis]
2 Zhang W, Wang J, Xie Z, Zou H, Chen Q, Xu L, Hu L, Fang N, Xu J, Zhou J, Liu J, Ran H, Wang Z, Zhang Y, Guo D. Antithrombotic Therapy by Regulating the ROS-Mediated Thrombosis Microenvironment and Specific Nonpharmaceutical Thrombolysis Using Prussian Blue Nanodroplets. Small 2022;:e2106252. [PMID: 35246943 DOI: 10.1002/smll.202106252] [Reference Citation Analysis]
3 Chen H, Sun T, Jiang C. Extracellular vesicle-based macromolecule delivery systems in cancer immunotherapy. J Control Release 2022;348:572-89. [PMID: 35714733 DOI: 10.1016/j.jconrel.2022.06.014] [Reference Citation Analysis]
4 Haddadzadegan S, Dorkoosh F, Bernkop-Schnürch A. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers. Adv Drug Deliv Rev 2022;182:114097. [PMID: 34999121 DOI: 10.1016/j.addr.2021.114097] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
5 Loloi J, Babar M, Davies KP, Suadicani SO. Nanotechnology as a tool to advance research and treatment of non-oncologic urogenital diseases. Therapeutic Advances in Urology 2022;14:175628722211090. [DOI: 10.1177/17562872221109023] [Reference Citation Analysis]
6 Jatal R, Mendes Saraiva S, Vázquez-vázquez C, Lelievre E, Coqueret O, López-lópez R, de la Fuente M. Sphingomyelin nanosystems decorated with TSP-1 derived peptide targeting senescent cells. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121618] [Reference Citation Analysis]
7 Huang J, Ding Y, Yao J, Zhang M, Zhang Y, Xie Z, Zuo J. Nasal Nanovaccines for SARS-CoV-2 to Address COVID-19. Vaccines 2022;10:405. [DOI: 10.3390/vaccines10030405] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Crintea A, Dutu AG, Sovrea A, Constantin AM, Samasca G, Masalar AL, Ifju B, Linga E, Neamti L, Tranca RA, Fekete Z, Silaghi CN, Craciun AM. Nanocarriers for Drug Delivery: An Overview with Emphasis on Vitamin D and K Transportation. Nanomaterials (Basel) 2022;12:1376. [PMID: 35458084 DOI: 10.3390/nano12081376] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]